Betterlife Pharma Stock Net Income

BETRF Stock  USD 0.07  0.01  14.62%   
BetterLife Pharma fundamentals help investors to digest information that contributes to BetterLife Pharma's financial success or failures. It also enables traders to predict the movement of BetterLife OTC Stock. The fundamental analysis module provides a way to measure BetterLife Pharma's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to BetterLife Pharma otc stock.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

BetterLife Pharma OTC Stock Net Income Analysis

BetterLife Pharma's Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.

Net Income

 = 

(Rev + Gain)

-

(Exp + Loss)

More About Net Income | All Equity Analysis

Current BetterLife Pharma Net Income

    
  (12.16 M)  
Most of BetterLife Pharma's fundamental indicators, such as Net Income, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, BetterLife Pharma is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
Competition

Based on the recorded statements, BetterLife Pharma reported net income of (12.16 Million). This is 103.56% lower than that of the Healthcare sector and 117.36% lower than that of the Biotechnology industry. The net income for all United States stocks is 102.13% higher than that of the company.

BetterLife Net Income Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses BetterLife Pharma's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of BetterLife Pharma could also be used in its relative valuation, which is a method of valuing BetterLife Pharma by comparing valuation metrics of similar companies.
BetterLife Pharma is currently under evaluation in net income category among its peers.

BetterLife Fundamentals

About BetterLife Pharma Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze BetterLife Pharma's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of BetterLife Pharma using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of BetterLife Pharma based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Currently Active Assets on Macroaxis

Other Information on Investing in BetterLife OTC Stock

BetterLife Pharma financial ratios help investors to determine whether BetterLife OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in BetterLife with respect to the benefits of owning BetterLife Pharma security.